PCA clinical trials at University of California Health

1 research study open to eligible people

PSMA PET Combined With MRI for the Detection of PCa
open to eligible males ages 18 years and up
This is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI) compared to standard of care (SOC) for the detection of prostate cancer (PCa).
at UCLA UCSF

Last updated: July 22, 2026